Risks associated with the evolution in the compounding process of parenteral nutrition solutions: use of the “FMECA” method

Abstract

An audit of the practices of our compounding unit was performed in 2016: areas of improvement were proposed, such as the automatization of our process. An automated compounder was acquired (MediMixmulti® MF4120R). The aim of the study was to anticipate the risks of the new process, in order to improve its security and to support the professionals during this evolution of our compounding process.

Keywords

• hazard analysis and critical control points
• neonatology
• parenteral nutrition
• risk management